EPHA7, a new target gene for 6q deletion in T-cell lymphoblastic lymphomas

Carcinogenesis

Volumn 33, Issue 2, 2012, Pages 452-458

  oĹpez nieva, Pilar ^a,b   Vaquero, Concepción ^a   Fernández navarro, Pablo ^c,d   González sánchez, Laura ^a,e   Villa morales, María ^a,e   Santos, Javier ^a,e   Esteller, Manel ^b   Fernández piqueras, José ^a,e  

^a CSIC   (Spain)

^b BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^c CARLOS III INSTITUTE OF HEALTH   (Spain)

^d CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CASP8AP2 PROTEIN; EPHRIN RECEPTOR A7; GRIK2 PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHROMOSOME 6Q; CHROMOSOME DELETION; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; FEMALE; FETUS; GENE EXPRESSION REGULATION; GENE INACTIVATION; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; LEUKEMOGENESIS; LYMPHOBLASTOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TUMOR SUPPRESSOR GENE;

EID: 84856562941     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr271     Document Type: Article

References (50)

1. Aifantis, I. et al. (2008) Molecular pathogenesis of T-cell leukaemia and lymphoma. Nat. Rev. Immunol., 8, 380-390.
2. Graux, C. et al. (2006) Cytogenetics and molecular genetics of T-cell acute lymphoblastic leukemia: from thymocyte to lymphoblast. Leukemia, 20, 1496-1510.
3. Sinclair, P.B. et al. (2004) A fluorescence in situ hybridization map of 6q deletions in acute lymphocytic leukemia: identification and analysis of a candidate tumor suppressor gene. Cancer Res., 64, 4089-4098.
4. Remke, M. et al. (2009) High-resolution genomic profiling of childhood TALL reveals frequent copy-number alterations affecting the TGF-beta and PI3K-AKT pathways and deletions at 6q15-16.1 as a genomic marker for unfavorable early treatment response. Blood, 114, 1053-1062.
5. Kimm, L.R. et al. (2007) Frequent occurrence of deletions in primary mediastinal B-cell lymphoma. Genes Chromosomes Cancer, 46, 1090-1097.
6. Thelander, E.F. et al. (2008) Characterization of 6q deletions in mature B cell lymphomas and childhood acute lymphoblastic leukemia. Leuk. Lymphoma, 49, 477-487.
7. Mohamed, A.N. et al. (2007) Chromosome aberrations in a series of 120 multiple myeloma cases with abnormal karyotypes. Am. J. Hematol., 82, 1080-1087.
8. Kang, N. et al. (2007) A combined strategy of conventional cytogenetics, fluorescent in situ hybridization and microsatellite polymerase chain reaction to analyze the deletion of chromosome 6 in laryngeal squamous cell carcinoma. Oncol. Rep., 18, 1379-1385.
9. Blaker, H. et al. (2008) Recurrent deletions at 6q in early age of onset non-HNPCC- and non-FAP-associated intestinal carcinomas. Evidence for a novel cancer susceptibility locus at 6q14-q22. Genes Chromosomes Cancer, 47, 159-164.
10. van Gils, W. et al. (2008) Regional deletion and amplification on chromosome 6 in a uveal melanoma case without abnormalities on chromosomes 1p, 3 and 8. Melanoma Res., 18, 10-15.
11. Monoranu, C.M. et al. (2008) Correlation between 6q25.3 deletion status and survival in pediatric intracranial ependymomas. Cancer Genet. Cytogenet., 182, 18-26.
12. Gorringe, K.L. et al. (2009) Are there any more ovarian tumor suppressor genes? A new perspective using ultra high-resolution copy number and loss of heterozygosity analysis. Genes Chromosomes Cancer, 48, 931-942.
13. Stein, L. et al. (2010) Copy number and gene expression alterations in radiation-induced papillary thyroid carcinoma from chernobyl pediatric patients. Thyroid, 20, 475-487.
14. Saito, S. et al. (2009) High frequency of common DNA copy number abnormalities detected by bacterial artificial chromosome array comparative genomic hybridization in 24 breast cancer cell lines. Hum. Cell, 22, 1-10.
15. Jaffe, E.S. et al. (2008) Classification of lymphoid neoplasms: the microscope as a tool for disease discovery. Blood, 112, 4384-4399.
16. Santos, J. et al. (2002) A new locus for resistance to gamma-radiationinduced thymic lymphoma identified using inter-specific consomic and interspecific recombinant congenic strains of mice. Oncogene, 21, 6680-6683.
17. Guerrero, I. et al. (1984) Activation of a c-K-ras oncogene by somatic mutation in mouse lymphomas induced by gamma radiation. Science, 225, 1159-1162.
18. Guerrero, I. et al. (1986) Oncogene activation and surface markers in mouse lymphomas induced by radiation and nitrosomethylurea. Leuk. Res., 10, 851-858.
19. Melendez, B. et al. (1999) Loss of heterozygosity at the proximal-mid part of mouse chromosome 4 defines two novel tumor suppressor gene loci in Tcell lymphomas. Oncogene, 18, 4166-4169.
20. D'Haene, B. et al. (2010) Accurate and objective copy number profiling using real-time quantitative PCR. Methods, 50, 262-270.
21. Livak, K.J. et al. (2001) Analysis of relative gene expression data using realtime quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25, 402-408.
22. Herman, J.G. et al. (1996) Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl Acad. Sci. USA, 93, 9821-9826.
23. Dawson, D.W. et al. (2007) Global DNA methylation profiling reveals silencing of a secreted form of Epha7 in mouse and human germinal center B-cell lymphomas. Oncogene, 26, 4243-4252.
24. Malumbres, M. et al. (1999) Hypermethylation of the cell cycle inhibitor p15INK4b 3'-untranslated region interferes with its transcriptional regulation in primary lymphomas. Oncogene, 18, 385-396.
25. Santos, J. et al. (2001) Evidence of a possible epigenetic inactivation mechanism operating on a region of mouse chromosome 19 in gamma-radiationinduced thymic lymphomas. Oncogene, 20, 2186-2189.
26. de Yzaguirre, M.M. et al. (2006) Epigenetic silencing of E- and N-cadherins in the stroma of mouse thymic lymphomas. Carcinogenesis, 27, 1081-1089.
27. Bueno, M.J. et al. (2008) Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell, 13, 496-506.
28. Gerard, B. et al. (1997) Delineation of a 6 cM commonly deleted region in childhood acute lymphoblastic leukemia on the 6q chromosomal arm. Leukemia, 11, 228-232.
29. Hatta, Y. et al. (1999) Detailed deletion mapping of the long arm of chromosome 6 in adult T-cell leukemia. Blood, 93, 613-616.
30. Hayashi, Y. et al. (1990) Abnormalities of the long arm of chromosome 6 in childhood acute lymphoblastic leukemia. Blood, 76, 1626-1630.
31. Merup, M. et al. (1998) 6q deletions in acute lymphoblastic leukemia and non-Hodgkin's lymphomas. Blood, 91, 3397-3400.
32. Offit, K. et al. (1993) 6q deletions define distinct clinico-pathologic subsets of non-Hodgkin's lymphoma. Blood, 82, 2157-2162.
33. Takeuchi, S. et al. (1998) Frequent loss of heterozygosity on the long arm of chromosome 6: identification of two distinct regions of deletion in childhood acute lymphoblastic leukemia. Cancer Res., 58, 2618-2623.
34. Zhang, Y. et al. (2000) A 3-cM commonly deleted region in 6q21 in leukemias and lymphomas delineated by fluorescence in situ hybridization. Genes Chromosomes Cancer, 27, 52-58.
35. Burkhardt, B. et al. (2008) Pediatric precursor T lymphoblastic leukemia and lymphoblastic lymphoma: differences in the common regions with loss of heterozygosity at chromosome 6q and their prognostic impact. Leuk. Lymphoma, 49, 451-461.
36. Bueno, M.J. et al. (2011) Combinatorial effects of microRNAs to suppress the Myc oncogenic pathway. Blood, 117, 6255-6266.
37. Esteller, M. (2003) Profiling aberrant DNA methylation in hematologic neoplasms: a view from the tip of the iceberg. Clin. Immunol., 109, 80-88.
38. Esteller, M. et al. (2002) Hypermethylation of the DNA repair gene O(6)-methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphoma. J. Natl. Cancer Inst., 94, 26-32.
39. Nakanishi, H. et al. (2007) ALL1 fusion proteins induce deregulation of EphA7 and ERK phosphorylation in human acute leukemias. Proc. Natl Acad. Sci. USA, 104, 14442-14447.
40. Hafner, C. et al. (2004) Differential gene expression of Eph receptors and ephrins in benign human tissues and cancers. Clin. Chem., 50, 490-499.
41. Surawska, H. et al. (2004) The role of ephrins and Eph receptors in cancer. Cytokine Growth Factor Rev., 15, 419-433.
42. Wang, L.F. et al. (2008) Increased expression of EphA7 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients. BMC Cancer, 8, 79.
43. Wang, J. et al. (2005) Downregulation of EphA7 by hypermethylation in colorectal cancer. Oncogene, 24, 5637-5647.
44. Oudes, A.J. et al. (2005) Application of affymetrix array and massively parallel signature sequencing for identification of genes involved in prostate cancer progression. BMC Cancer, 5, 86.
45. Wang, J. et al. (2007) Differential expression of EphA7 receptor tyrosine kinase in gastric carcinoma. Hum. Pathol., 38, 1649-1656.
46. Guan, M. et al. (2009) Aberrant methylation of EphA7 in human prostate cancer and its relation to clinicopathologic features. Int. J. Cancer, 124, 88-94.
47. Pasquale, E.B. (2005) Eph receptor signalling casts a wide net on cell behaviour. Nat. Rev. Mol. Cell Biol., 6, 462-475.
48. Wu, J. et al. (2005) Recent advances on T-cell regulation by receptor tyrosine kinases. Curr. Opin. Hematol., 12, 292-297.
49. Freywald, A. et al. (2006) EphA receptors inhibit anti-CD3-induced apoptosis in thymocytes. J. Immunol., 176, 4066-4074.
50. Perez de Castro, I.P. et al. (1999) Cooperative alterations of Rb pathway regulators in mouse primary T cell lymphomas. Carcinogenesis, 20, 1675-1682.